Avrobio Inc (AVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVRO | AMGN | VRTX | BMY | REGN |
| Company | Avrobio Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.2300 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 1.2300 | 322.60 | 405.67 | 44.33 | 947.08 |
| Low | 1.2100 | 310.65 | 397.59 | 43.81 | 926.94 |
| Last | 1.2100 | 314.04 | 398.19 | 43.78 | 940.00 |
| Change | -0.0200 | +35.65 | -1.97 | +0.08 | +2.39 |
| % Change | -1.63% | +12.81% | -0.49% | +0.18% | +0.25% |
| Volume | 32,669 | 4,348,349 | 173,253 | 2,720,695 | 87,428 |
| 20-Day Average Volume | 171,163 | 2,367,518 | 975,918 | 13,975,828 | 494,693 |
| Previous Close | 1.2300 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2263 | 272.38 | 398.35 | 47.47 | 909.01 |
| 20-Day Raw Stochastic | 33.33% | 85.42% | 53.64% | 8.53% | 87.28% |
| 20-Day Relative Strength | 44.44% | 72.85% | 45.91% | 29.58% | 54.77% |
| Weighted Alpha | +1.72 | +35.06 | +13.76 | -36.56 | +23.62 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 100% Sell | 48% Buy |
| Previous Opinion | 88% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 72% Sell | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/26/24 | +16.15% since 04/26/24 | +0.52% since 04/26/24 | -1.79% since 04/26/24 | +6.41% since 04/26/24 |
| Low | 1.1705 on 05/01/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 1.2500 on 05/02/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 947.08 on 05/03/24 |
| 1-Month | |||||
| %Chg | -6.92% since 04/03/24 | +14.27% since 04/03/24 | -2.26% since 04/03/24 | -15.59% since 04/03/24 | -1.17% since 04/03/24 |
| Low | 1.1700 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 1.3100 on 04/05/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -5.47% since 02/02/24 | -2.98% since 02/02/24 | -5.92% since 02/02/24 | -9.58% since 02/02/24 | -0.57% since 02/02/24 |
| Low | 1.1500 on 03/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 1.3600 on 03/01/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -23.42% since 11/03/23 | +16.20% since 11/03/23 | +6.21% since 11/03/23 | -16.61% since 11/03/23 | +15.04% since 11/03/23 |
| Low | 1.0100 on 01/30/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 1.6050 on 11/06/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 55,179 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 44,861 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | 12,160,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -8,780,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.24 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 11/09/23 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |